INFANT HEMISPHERIC GLIOMA: CLINICAL AND MOLECULAR CHARACTERISTICS AND RESULTS OF TARGETED THERAPY.

被引：0
|
作者：
Papusha, Ludmila [1 ]
Druy, Alexander [1 ]
Zaytseva, Margarita [1 ]
Salnikova, Ekaterina [1 ]
Panferova, Agnesa [1 ]
Samarin, Alexey [1 ]
Novichkova, Galina [1 ]
Hwang, Eugene [2 ]
Packer, Roger [2 ]
机构：
[1] D Rogachev Natl Med Res Ctr Pediat Hematol Oncol, Moscow, Russia
[2] Childrens Natl Hosp, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad073.161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HGG-12
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Infant-Type Hemispheric Glioma: New Molecular Alterations and Precision-Medicine Treatment
    Hu, Wan-Ming
    Yuan, Li
    Zeng, Jing
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1193 - 1194
  • [12] INFANT-TYPE HEMISPHERIC GLIOMA: NEW MOLECULAR ALTERATIONS AND PRECISION-MEDICINE TREATMENT
    Hu, Wanming
    Yuan, Li
    Zeng, Jing
    NEURO-ONCOLOGY, 2022, 24 : 157 - 158
  • [13] INFANT-TYPE HEMISPHERIC GLIOMA: NEW MOLECULAR ALTERATIONS AND PRECISION-MEDICINE TREATMENT
    Hu, Wanming
    Yuan, Li
    Zeng, Jing
    NEURO-ONCOLOGY, 2023, 25
  • [14] Infant-Type Hemispheric Glioma: New Molecular Alterations and Precision-Medicine Treatment
    Hu, Wan-Ming
    Yuan, Li
    Zeng, Jing
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1193 - 1194
  • [15] Molecular Targeted Therapy of Biliary Tract Cancer - Results of the First Clinical Studies
    Wiedmann, Marcus W.
    Moessner, Joachim
    CURRENT DRUG TARGETS, 2010, 11 (07) : 834 - 850
  • [16] CLINICAL, PATHOLOGICAL AND MOLECULAR DISEASE CHARACTERISTICS OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT
    Le Rhun, E.
    Bink, A.
    Felsberg, J.
    Gramatzki, D.
    Brandner, S.
    Benhamida, J. K.
    Wick, A.
    Tonn, J. C.
    Mohme, M.
    Tabatabai, G.
    Capper, D.
    Snuderl, M.
    Razis, E.
    Ronellenfitsch, M.
    Neidert, N.
    Ng, H.
    Pohl, U.
    Bale, T. A.
    Quach, S.
    Rieger, D.
    Schueller, U.
    Drueschler, K.
    Healy, E.
    Graham, M.
    Paine, S. M. L.
    Medici, V
    Sievers, P.
    Schrimpf, D.
    Wick, W.
    Sahm, F.
    Reifenberger, G.
    von Deimling, A.
    Weller, M.
    NEURO-ONCOLOGY, 2024, 26 : V118 - V118
  • [17] CLINICAL, PATHOLOGICAL AND MOLECULAR DISEASE CHARACTERISTICS OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT
    Le Rhun, Emilie
    Bink, Andrea
    Felsberg, Joerg
    Gramatzki, Dorothee
    Brandner, Sebastian
    Benhamida, Jamal K.
    Wick, Antje
    Tonn, Joerg C.
    Mohme, Malte
    Tabatabai, Ghazaleh
    Capper, David
    Snuderl, Matija
    Razis, Evangelia
    Ronellenfitsch, Michael
    Neidert, Nicolas
    Ng, Ho-Keung
    Pohl, Ute
    Bale, Tejus
    Quach, Stefanie
    Rieger, David
    Schueller, Ulrich
    Onken, Julia
    Drueschler, Katharina
    Maurage, Claude Alain
    Regli, Luca
    Healy, Estelle
    Graham, Maya
    Hortobagyi, Tibor
    Paine, Simon
    Ansorge, Olaf
    Bridges, Leslie
    Lausova, Tereza
    Medici, Valentina
    Sievers, Philipp
    Schrimpf, Daniel
    Wick, Wolfgang
    Sahm, Felix
    Reifenberger, Guido
    von Deimling, Andreas
    Weller, Michael
    NEURO-ONCOLOGY, 2024, 26
  • [18] Rapid assessment of malignant glioma susceptibility to molecular targeted therapy
    Huamani, J.
    Passarella, R. J.
    Onishko, H. M.
    Fu, A.
    Geng, L.
    Han, Z.
    Hallahan, D. E.
    Diaz, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S149 - S149
  • [19] Targeted Glioma Therapy-Clinical Trials and Future Directions
    Shikalov, Aleksandr
    Koman, Igor
    Kogan, Natalya M.
    PHARMACEUTICS, 2024, 16 (01)
  • [20] Antisense molecules for targeted cancer therapy. Scientific aspects and clinical perspectives
    Zangemeister-Wittke, U.
    ONKOLOGE, 2007, 13 (03): : 256 - +
12345